For example, HepG2 cells have been reported to carry the PNPLA3 variant that is associated with PNPLA3 NAFLD and so might not be appropriate to use when modelling metabolic NAFLD (Green et al., 2015a; Luukkonen et al., 2016). Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.